4.6 Article

Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial

Amit Bar-Or et al.

ANNALS OF NEUROLOGY (2008)

Article Medicine, General & Internal

B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis

Stephen L. Hauser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Clinical Neurology

The immunopathology of multiple sclerosis:: An overview

Hans Lassmann et al.

BRAIN PATHOLOGY (2007)

Article Immunology

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

Anne H. Cross et al.

JOURNAL OF NEUROIMMUNOLOGY (2006)

Article Clinical Neurology

Immune surveillance in multiple sclerosis patients treated with natalizumab

O Stüve et al.

ANNALS OF NEUROLOGY (2006)

Review Medicine, General & Internal

Medical progress: Multiple sclerosis - The plaque and its pathogenesis

EM Frohman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Clinical Neurology

Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria

CH Polman et al.

ANNALS OF NEUROLOGY (2005)

Article Immunology

Unveiling the enigma of the CNS as a B-cell fostering environment

A Uccelli et al.

TRENDS IN IMMUNOLOGY (2005)

Article Multidisciplinary Sciences

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis

A Corcione et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)